Acute Valve Syndrome Before Aortic Valve Replacement: Impact on Clinical Outcomes, Health Care Costs, and Resource Use
Journal of the American Heart Association · 07.10.2025 · 14 (19)
DOI: 10.1161/jaha.125.043486 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 07.10.2025. Verfasst von Philippe Généreux und 14 weiteren Autor:innen. Beteiligte Einrichtung: Gagnon Cardiovascular Institute, Morristown Medical Center Morristown NJ USA. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Heart Valve Prosthesis Implantation, Health Care Costs, Health Resources. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
A classification system describing clinical presentation before aortic valve replacement (AVR) has recently been proposed (stable valve syndrome [SVS]), mildly symptomatic (progressive valve syndrome), or with acute and severe signs and symptoms (acute valve syndrome [AVS]). We aimed to evaluate the clinical impact, health care costs, and resource use associated with the mode of clinical presentation at the time of AVR among patients presenting with aortic stenosis.
Methods
Using the Market Clarity database (2017–2023), patients >18 years old with aortic stenosis and undergoing AVR (transcatheter or surgical) were included. Patients were categorized as SVS, progressive valve syndrome, or AVS based on their clinical presentation during the 1 year before AVR. All‐cause death, heart failure hospitalization, total health care costs (index hospitalization plus 1‐year follow‐up), and resource use were compared across clinical presentation groups using adjusted regression models.
Results
Of the 24 075 patients undergoing AVR for aortic stenosis, 270 (1.1%) had SVS, 10 195 (42.3%) progressive valve syndrome, and 13 610 (56.5%) AVS. Compared with SVS, AVS presentation was associated with increased risk of 1‐year death (adjusted hazard ratio [aHR], 2.93 [95% CI, 1.1–7.8]; P =0.03) and heart failure hospitalization (aHR, 4.15 [95% CI, 1.6–11.1]; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gagnon Cardiovascular Institute, Morristown Medical Center Morristown NJ USA.
- Vanderbilt University Medical Center Nashville TN USA.
- Laval University Quebec City Quebec Canada.
- Massachusetts General Hospital Boston MA USA.
- Baim Institute of Clinical Research Boston MA USA.
- Edwards Lifesciences Irvine CA USA.
ORCID-Profile: Philippe Généreux, Brian R Lindman, Philippe Pibarot, Suzanne J Baron, Chantal Asselin, Alissa Dratch, Shannon M E Murphy, Soumya Chikermane, Kostantinos P Koulogiannis, Allan Schwartz, Martin B Leon, Patricia P Pellikka, Linda D Gillam
Zitieren
APA
Généreux, P., Giustino, G., Lindman, B. R., Pibarot, P., Baron, S. J., Asselin, C., Dratch, A., Murphy, S. M. E., Chikermane, S., Thourani, V. H., Koulogiannis, K. P., Schwartz, A., Leon, M. B., Pellikka, P. P., & Gillam, L. D. (2025). Acute Valve Syndrome Before Aortic Valve Replacement: Impact on Clinical Outcomes, Health Care Costs, and Resource Use. Journal of the American Heart Association, 14(19). https://doi.org/10.1161/jaha.125.043486
Vancouver
Généreux P, Giustino G, Lindman BR, Pibarot P, Baron SJ, Asselin C, et al. Acute Valve Syndrome Before Aortic Valve Replacement: Impact on Clinical Outcomes, Health Care Costs, and Resource Use. Journal of the American Heart Association. 2025;14(19). doi:10.1161/jaha.125.043486
BibTeX
@article{Gnreux2025,
author = {Généreux, Philippe and Giustino, Gennaro and Lindman, Brian R and Pibarot, Philippe and Baron, Suzanne J and Asselin, Chantal and Dratch, Alissa and Murphy, Shannon M E and Chikermane, Soumya and Thourani, Vinod H and Koulogiannis, Kostantinos P and Schwartz, Allan and Leon, Martin B and Pellikka, Patricia P and Gillam, Linda D},
title = {Acute Valve Syndrome Before Aortic Valve Replacement: Impact on Clinical Outcomes, Health Care Costs, and Resource Use},
journal = {Journal of the American Heart Association},
year = {2025},
volume = {14},
number = {19},
doi = {10.1161/jaha.125.043486}
}
EUVIMED